OPDP Sends Untitled Letter to Merz Over Social Media Post
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
False Claims
Humana Reaches $90 Million Settlement in First of Its Kind False Claims Act…
Humana recently reached a $90 million settlement with the United States to resolve allegations that Humana submitted fraudulent…
Policy and Medicine Compliance Update June 2023 Issue Features Update on…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Policy and Medicine Compliance Update April 2023 Issue Features: DOJ’s…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Policy and Medicine March 2022 Issue Features FDA Exclusivity, Baby Powder,…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Policy and Medicine Compliance Update February 2022 Issue Focuses on…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…